This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Up 6.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is CVS Health (CVS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
HealthEquity Acquires WageWorks, To Make Notable Investments
by Zacks Equity Research
HealthEquity (HQY) expects to complete its $80-100 million investment program within 24-36 months from now.
Zacks.com featured highlights include: CVS Health, Asbury Automotive, Anixter International, Cincinnati Bell and AmerisourceBergen
by Zacks Equity Research
Zacks.com featured highlights include: CVS Health, Asbury Automotive, Anixter International, Cincinnati Bell and AmerisourceBergen
Recent Broker Rating Upgrades Add Luster to These 5 Stocks
by Maharathi Basu
Since brokers follow stocks in their coverage minutely, their advice is invaluable for individual investors as the latter aim for lucrative returns.
Top Ranked Momentum Stocks to Buy for August 29th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 29th
Is Deep Value ETF (DVP) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVP
CVS Health Banks on Health Care Benefit Prospects Amid Woes
by Zacks Equity Research
CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition is gaining a strong momentum.
Zacks.com featured highlights include: Diebold Nixdorf, CVS Health, AmerisourceBergen, AutoNation and Clearwater Paper
by Zacks Equity Research
Zacks.com featured highlights include: Diebold Nixdorf, CVS Health, AmerisourceBergen, AutoNation and Clearwater Paper
5 Stocks That Brokers Currently Love
by Maharathi Basu
Investors aim to generate maximum returns from their portfolio. Therefore, it is in their best interests to pay heed to well-researched information accumulated by brokers.
Should Value Investors Buy CVS Health (CVS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CVS Stock Jumps 7% After Strong Earnings: What's Next for the Pharmacy Giant?
by Zachary Stutler
CVS (CVS) reported its Q2 earnings results Wednesday morning and beat our estimates by 11%.
Company News for Aug 8, 2019
by Zacks Equity Research
Companies in the news are: DIS, CVS, CPRI and ODP
CVS Health (CVS) Beats on Q2 Earnings, Raises '19 Guidance
by Zacks Equity Research
CVS Health's (CVS) second-quarter top-line growth in Pharmacy Services segment is backed by an uptick in specialty services.
U.S. Stock Index Futures Move Lower
by Zacks Equity Research
U.S. stock index futures moved lower
Stock Futures Fall as Trade Worries Spook Wall Street
by Zacks Equity Research
U.S. stock index futures moved lower ahead of trading on Wednesday after rising trade tensions led to concerns that a global economic slowdown was likely.
CVS Health (CVS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 11.18% and 1.31%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Outlook for Health Insurance Industry Looks Sanguine
by Sapna Bagaria
Consolidation, increasing senior population, technological advancements and development of supplementary healthcare businesses poise the health insurance industry for secular growth.
Buy CVS Health (CVS) Ahead of Q2 Earnings?
by Christopher Vargas
CVS Health (CVS) will be reporting their second quarter before the opening bell on Wednesday.
Can Pharmacy Services Drive CVS Health's (CVS) Q2 Earnings?
by Zacks Equity Research
Akin to the previous quarters, net new business and the steady uptake of Maintenance Choice programs are likely to bolster CVS Health's (CVS) PBM business in Q2.
Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2?
by Zacks Equity Research
Within the Health Care Benefits segment, CVS Health (CVS) expects the government programs to go from strength to strength on the back of Medicare growth and major Medicaid wins.
3 Retail Stocks Likely to Stand Tall This Earnings Season
by Zacks Equity Research
Retailers are making prudent investments to strengthen digital ecosystem and bolster shipping and delivery capabilities. While these drive sales, they entail high costs. Margins remain one of the key areas to watch.
Cigna (CI) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Cigna's (CI) Q2 earnings should reflect increase in revenues from growth across its segments and share buyback.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $56.26, marking a +1.3% move from the previous day.
Is Deep Value ETF (DVP) a Strong ETF Right Now?
by Sweta Killa
Smart Beta ETF report for DVP